BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9678442)

  • 1. Efficacy of interferon alpha in acute hepatitis C in patients on chronic hemodialysis.
    Süleymanlar I; Sezer T; Işitan F; Yakupoglu G; Süleymanlar G
    Nephron; 1998; 79(3):353-4. PubMed ID: 9678442
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of chronic hepatitis C with interferon alpha in patients on maintenance hemodialysis.
    Djordjević V; Kostić S; Stefanović V
    Nephron; 1998; 79(2):229-31. PubMed ID: 9647511
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of hepatitis C with interferon-alpha in hemodialysis patients].
    Degos F
    Nephrologie; 1997; 18(7):279-80. PubMed ID: 9496567
    [No Abstract]   [Full Text] [Related]  

  • 4. Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C.
    Liu CH; Liang CC; Liu CJ; Lin JW; Chen SI; Hung PH; Tsai HB; Lai MY; Chen PJ; Chen DS; Kao JH
    Clin Infect Dis; 2010 Sep; 51(5):541-9. PubMed ID: 20645865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of interferon re-therapy and its adaptation in chronic hepatitis C].
    Matsuo S; Ohnishi K; Fujiwara K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):1012-6. PubMed ID: 7563658
    [No Abstract]   [Full Text] [Related]  

  • 7. [How should hepatitis C be treated? Treatment of hepatitis C with interferon].
    Marcellin P
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S81-8. PubMed ID: 9161518
    [No Abstract]   [Full Text] [Related]  

  • 8. [Successful treatment in a case of type-C fulminant hepatitis with interferon and steroid-pulse therapy, and review of its virological aspects].
    Marusawa H; Yamashita Y; Kajimura K; Kumegawa Y; Takaya H; Katsurada A
    Nihon Shokakibyo Gakkai Zasshi; 1996 Aug; 93(8):583-7. PubMed ID: 8810818
    [No Abstract]   [Full Text] [Related]  

  • 9. Summaries for patients. Pegylated interferon with or without ribavirin for patients with hepatitis C receiving hemodialysis.
    Ann Intern Med; 2013 Dec; 159(11):I-14. PubMed ID: 24297207
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term efficacy of pegylated interferon alpha-2a in HCV-positive hemodialysis patients.
    Ucmak H; Kokoglu OF; Hosoglu S; Dogan E; Sayarlioglu H; Kuzhan N; Isik IO
    Ren Fail; 2008; 30(2):227-32. PubMed ID: 18300126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon may be useful in hemodialysis patients with hepatitis C virus chronic infection who are candidates for kidney transplant.
    Casanovas Taltavull T; Baliellas C; Sesé E; Iborra MJ; Benasco C; Andrés E; González MT; Gil-Vernet S; Casanova A; Casais LA
    Transplant Proc; 1995 Aug; 27(4):2229-30. PubMed ID: 7652784
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of pegylated interferon base treatment in patients with chronic hepatitis C on dialysis.
    Ahn SB; Jun DW; Kim SG; Lee SH; Shin HP; Choe WH; Kim JK; Jung KS; Kim DY; Shim JJ; Park SY; Seo YS; Kim W; Chung JI
    Eur J Intern Med; 2015 May; 26(4):292-6. PubMed ID: 25877760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long term/intermittent treatment of chronic hepatitis C with recombinant interferon alfa-2b].
    Hakozaki Y; Fujioka T; Katou M; Kondo T; Oba K; Nakagawa K; Shirahama T
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):1001-6. PubMed ID: 7563656
    [No Abstract]   [Full Text] [Related]  

  • 14. [Two cases of acute exacerbation of chronic hepatitis C improved after the administration of an immunosuppressive drug and interferon].
    Ikeda H; Nishina K; Asatani Y; Yumoto E; Okano N; Seno H; Yamano T; Kiyono T; Konishi A; Inoue T
    Nihon Shokakibyo Gakkai Zasshi; 1995 Aug; 92(8):1200-5. PubMed ID: 7563929
    [No Abstract]   [Full Text] [Related]  

  • 15. [Interferon treatment for chronic hepatitis C--assessment of 3 regimens in patients received more than 500 MU interferon treatment and their effect predictive factors for interferon treatment using multivariate analysis with the logistic regression model].
    Terada M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):1007-11. PubMed ID: 7563657
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of hepatitis C virus infection in patients on maintenance hemodialysis: a single United Arab Emirates center experience.
    Giguere A; Anas A; Nasser T; Hassan MH; Ahmed U; Beejay N; Nouh M; Khalowf M; Saleh A; Khan A; Attia M; El-Azab G
    Eur J Intern Med; 2011 Dec; 22(6):582-6. PubMed ID: 22075284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of breakthrough in chronic hepatitis C patients undergoing antiviral therapy: role of type and schedule of alpha interferon C.H.S.G.
    Bellati G; Colloredo G; Roffi L; D'Aquino M; Bonino F; Idéo G
    J Hepatol; 1997 Feb; 26(2):449-50. PubMed ID: 9059974
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of hepatitis C in hemodialysis patients with pegylated interferon alpha-2a as monotherapy.
    Sikole A; Dzekova P; Selja N; Gaseva M; Nikolov IG; Zabzun M; Muharemi S; Asani A; Amitov V; Mena S; Grunevska V; Ivanovski L; Polenakovic M
    Ren Fail; 2007; 29(8):961-6. PubMed ID: 18067041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to alpha 2B interferon (IFN) treatment in a haemodialysis patient with chronic hepatitis C.
    Barril G; Schez Tomero JA; Garcia Buey L; Motellon JL; Bernis C; Traver JA
    Nephrol Dial Transplant; 1994; 9(9):1354-5. PubMed ID: 7816309
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of pegylated interferon alfa-2b and ribavirin combination therapy versus pegylated interferon monotherapy in hemodialysis patients: a comparison of 2 sequentially treated cohorts.
    Tseng PL; Chen TC; Chien YS; Hung CH; Yen YH; Chang KC; Tsai MC; Lin MT; Lee CT; Shen CH; Hu TH
    Am J Kidney Dis; 2013 Oct; 62(4):789-95. PubMed ID: 23746377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.